NeoGenomics
Business Services · Florida, United States · 1K - 5K Employees
View Company Info for Free
Overview
Headquarters
9490 Neogenomics Way, Fort Myers, Florid...Phone Number
(239) 768-0600Website
www.neogenomics.comRevenue
$746 MillionStock Symbol
NEOIndustry
ZI Rank: 2
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
4
3
1
6
1
2
About NeoGenomics
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study normal and abnormal chromosomes and their relationship to diseases; fluorescence in-situ hybridization testing services that focus on detecting and locating the presence or absence of specific DNA sequences and genes on chromosomes; flow cytometry testing services to measure the characteristics of cell populations; immunohistochemistry and digital imaging testing services to localize proteins in cells of a tissue section, as well as to allow clients to see and utilize scanned slides, and perform quantitative analysis for various stains; and molecular testing services that focus on the analysis of DNA and RNA, and the structure and function of geneRead more
NeoGenomics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is NeoGenomics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Check if NeoGenomics has recently received funding, and reach out quickly before it becomes old news!
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Click to see if NeoGenomics had a recent Job posting/layoffs
Website visits: Recent activity has been detected on your website
Check out if NeoGenomics is spiking on competitors!
Earning: See what the market has to say on NeoGenomics recently announced quarterly report
NeoGenomics, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once NeoGenomics has new funding data
Product Launch: Get notified when NeoGenomics launches new products
Congratulate Masked Content for being promoted to Masked Content at NeoGenomics
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to NeoGenomics
Compare insights from companies similar to NeoGenomics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$232.5M
1K - 5K
Public
$195.5M
2010
EL
Ewa Lipinska-KowalikSenior Executive Administartive Partner To CEO
Company Profile Activity
Activity Insights
NeoGenomics is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
NeoGenomics is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about NeoGenomics.
NeoGenomics Tech Stack
A closer look at the technologies used by NeoGenomics
See more technologies
Most Recent Scoops
Open Position
Hiring Plans
NeoGenomics has more open roles in Information Technology than it has had at any time in the past 6 months. Technologies mentioned include: Linux. Areas of expertise include: Cppunit.
Hiring Plans
Open Position
Open Position
Person-Based
Earnings, Finance
NeoGenomics News & Media
NeoGenomics Appoints Carolyn Starrett to its Board of Directors - Yahoo Finance
FORT MYERS, Fla., June 25, 2026--NeoGenomics announced the appointment of Carolyn Starrett to its Board of Directors.NeoGenomics Q1 Earnings Call Highlights
NeoGenomics (NASDAQ:NEO) reported first-quarter 2026 results that management said reflected continued momentum in its clinical business and growing contributions from newer, higher-value oncology tests. Total revenue rose 11% year-over-year to $186.7 million, exceeding the company’s guidance, whileRedefining Hematologic Malignancy Drug Development: How Molecular Reclassification, MRD, & AI is Reshaping Precision Hematology, Upcoming Webinar Hosted by Xtalks
In this free webinar, gain insight into new changes in molecular reclassification of hematologic malignancies and their effects in precision medicine. Attendees will learn about the use of molecular residual disease (MRD) as a surrogate endpoint in hematological cancers. The featured...NeoGenomics (NEO) Launches RaDaR ST to Capture Share in $20B MRD Market
NeoGenomics Inc. (NASDAQ:NEO) is one of the most buzzing stocks to buy with the highest upside potential. On February 25, NeoGenomics officially launched RaDaR ST, a tumor-informed circulating tumor DNA/ctDNA assay designed to detect molecular residual disease/MRD across various solid tumor types. This launch targets a rapidly growing MRD market estimated at over $20 billion, […]
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding NeoGenomics
Sign Up For FreeTo access detailed company insights
NeoGenomics, Inc together with its subsidiaries, operates a network of cancer-focused genetic testing laboratories providing genetic and molecular testing services to hospitals, pathologists, oncologists, urologists, other clinicians and researchers, and other laboratories in the United States. It offers cytogenetics testing services to study norma... Read More
